Amino Acid Profiling in the Gestational Diabetes Mellitus

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2017 Apr 4

PMID 28367428

Citations 29

Authors

Najmeh Rahimi

Farideh Razi

Ensieh Nasli-Esfahani

Mostafa Qorbani

Nooshin Shirzad

Bagher Larijani

Affiliations

Soon will be listed here.

Abstract

Background: The prevalence of gestational diabetes mellitus (GDM) is increasing globally which is associated with various side effects for mothers and fetus. It seems that metabolomic profiling of the amino acids may be useful in early diagnosis of metabolic diseases. This study aimed to explore the association of the amino acids profiles with GDM.

Methods: Eighty three pregnant women with gestational age ≥25 weeks were randomly selected among pregnant women referred to prenatal care clinic in Arash hospital of Tehran, Iran. Women divided into three groups including 1) 25 pregnant women with normal glucose tolerance test, 2) 27 pregnant women with diabetes type 2 (T2D) (n: 27) and 3) 31 women with GDM (n: 31). Plasma levels of amino acids were measured by high performance liquid chromatography and were compared in three groups. Statistical analysis was performed using SPSS 16.

Results: Compared with normal mothers, GDM mothers showed higher plasma concentrations of Arginine ( = 0.01), Glycine ( = 0.01) and Methionine ( = 0.04), whereas the pregnant women with T2D had higher plasma levels of Asparagine ( = 0.01), Tyrosine ( < 0.01), Valine ( < 0.01), Phenylalanine ( < 0.01), Glutamine ( < 0.01) and Isolucine ( < 0.01). The results of regression analyses confirmed the significantly elevated in plasma concentration of Asparagine (OR:3.64, CI 1.22-10.47), Threonine (OR:3.38, CI 1.39-8.25), Aspartic acid (OR:3.92, CI 1.19-12.91), Phenylalanine (OR:2.66, CI 1.01-6.94), Glutamine (OR:2.53, CI 1.02-6.26) and Arginine (OR:1.96, CI 1.02-3.76) after adjustment for gestational age and BMI in GDM mothers compared to normal ones.

Conclusions: Amino acids levels are associated with risk of GDM and diabetes mellitus. However further prospective studies are needed to clarify the role of different metabolites involved in mechanism of GDM.

Citing Articles

Subcutaneous adipose tissue compensates for the perturbations in circulating one-carbon metabolism in women with gestational diabetes.

Wei X, Wei S, Chen M, Tan Y, Yang Z, Feng W Acta Diabetol. 2025; .

PMID: 39899132 DOI: 10.1007/s00592-025-02452-z.

Relationship Between Amino Acid Intake in Maternal Diet and Risk of Gestational Diabetes Mellitus: Results from the BORN 2020 Pregnant Cohort in Northern Greece.

Tranidou A, Siargkas A, Magriplis E, Tsakiridis I, Apostolopoulou A, Chourdakis M Nutrients. 2025; 17(1.

PMID: 39796608 PMC: 11723356. DOI: 10.3390/nu17010173.

Neonatal amino acid metabolism in gestational diabetes mellitus mothers treated with different treatment strategies.

Zhu X, Wang W, Yang Y, Zhou H, Long W, Zhang B J Diabetes Metab Disord. 2024; 24(1):18.

PMID: 39712342 PMC: 11659532. DOI: 10.1007/s40200-024-01522-3.

Omics experiments in Iran, a review in endocrine and metabolism disorders studies.

Hosseinkhani S, Arjmand B, Bandarian F, Aazami H, Hadizadeh N, Najjar N J Diabetes Metab Disord. 2024; 23(2):1539-1544.

PMID: 39610495 PMC: 11599483. DOI: 10.1007/s40200-021-00727-0.

Association of maternal blood metabolomics and gestational diabetes mellitus risk: a systematic review and meta-analysis.

Zhou J, Yu J, Ren J, Ren Y, Zeng Y, Wu Y Rev Endocr Metab Disord. 2024; .

PMID: 39602052 DOI: 10.1007/s11154-024-09934-5.

References

Wurtz P, Soininen P, Kangas A, Ronnemaa T, Lehtimaki T, Kahonen M . Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care. 2012; 36(3):648-55. PMC: 3579331. DOI: 10.2337/dc12-0895. View

Nasli-Esfahani E, Peimani M, Rambod C, Omidvar M, Larijani B . Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran. Iran J Public Health. 2015; 43(6):713-21. PMC: 4475590. View

Scholtens D, Muehlbauer M, Daya N, Stevens R, Dyer A, Lowe L . Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy. Diabetes Care. 2013; 37(1):158-66. PMC: 3867997. DOI: 10.2337/dc13-0989. View

Roberts L, Koulman A, Griffin J . Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2014; 2(1):65-75. DOI: 10.1016/S2213-8587(13)70143-8. View

Bentley-Lewis R, Huynh J, Xiong G, Lee H, Wenger J, Clish C . Metabolomic profiling in the prediction of gestational diabetes mellitus. Diabetologia. 2015; 58(6):1329-32. PMC: 4428592. DOI: 10.1007/s00125-015-3553-4. View

Hossein-Nezhad A, Maghbooli Z, Vassigh A, Larijani B . Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol. 2007; 46(3):236-41. DOI: 10.1016/S1028-4559(08)60026-1. View

Kim C . Gestational diabetes: risks, management, and treatment options. Int J Womens Health. 2010; 2:339-51. PMC: 2990903. DOI: 10.2147/IJWH.S13333. View

Nezami N, Safa J, Eftekhar-Sadat A, Salari B, Ghorashi S, Sakhaee K . Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. Clin Biochem. 2010; 43(16-17):1294-9. DOI: 10.1016/j.clinbiochem.2010.08.012. View

She P, Van Horn C, Reid T, Hutson S, Cooney R, Lynch C . Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab. 2007; 293(6):E1552-63. PMC: 2767201. DOI: 10.1152/ajpendo.00134.2007. View

10.

Smirnakis K, Plati A, Wolf M, Thadhani R, Ecker J . Predicting gestational diabetes: choosing the optimal early serum marker. Am J Obstet Gynecol. 2007; 196(4):410.e1-6. DOI: 10.1016/j.ajog.2006.12.011. View

11.

Jafari-Shobeiri M, Ghojazadeh M, Azami-Aghdash S, Naghavi-Behzad M, Piri R, Pourali-Akbar Y . Prevalence and Risk Factors of Gestational Diabetes in Iran: A Systematic Review and Meta-Analysis. Iran J Public Health. 2015; 44(8):1036-44. PMC: 4645723. View

12.

Seshiah V, Das A, Balaji V, Joshi S, Parikh M, Gupta S . Gestational diabetes mellitus--guidelines. J Assoc Physicians India. 2006; 54:622-8. View

13.

Irving B, Carter R, Soop M, Weymiller A, Syed H, Karakelides H . Effect of insulin sensitizer therapy on amino acids and their metabolites. Metabolism. 2015; 64(6):720-8. PMC: 4525767. DOI: 10.1016/j.metabol.2015.01.008. View

14.

Langer O, Yogev Y, Most O, Xenakis E . Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005; 192(4):989-97. DOI: 10.1016/j.ajog.2004.11.039. View

15.

Hajduk J, Klupczynska A, Derezinski P, Matysiak J, Kokot P, Nowak D . A Combined Metabolomic and Proteomic Analysis of Gestational Diabetes Mellitus. Int J Mol Sci. 2015; 16(12):30034-45. PMC: 4691080. DOI: 10.3390/ijms161226133. View

16.

Butte N, Hsu H, Thotathuchery M, Wong W, Khoury J, Reeds P . Protein metabolism in insulin-treated gestational diabetes. Diabetes Care. 1999; 22(5):806-11. DOI: 10.2337/diacare.22.5.806. View

17.

Beigi A, Shirzad N, Nikpour F, Nasli Esfahani E, Emamgholipour S, Bandarian F . Association between serum adropin levels and gestational diabetes mellitus; a case-control study. Gynecol Endocrinol. 2015; 31(12):939-41. DOI: 10.3109/09513590.2015.1081681. View

18.

Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost H . Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2012; 62(2):639-48. PMC: 3554384. DOI: 10.2337/db12-0495. View

19.

Metzger B, Phelps R, Freinkel N, Navickas I . Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care. 1980; 3(3):402-9. DOI: 10.2337/diacare.3.3.402. View

20.

Pappa K, Vlachos G, Theodora M, Roubelaki M, Angelidou K, Antsaklis A . Intermediate metabolism in association with the amino acid profile during the third trimester of normal pregnancy and diet-controlled gestational diabetes. Am J Obstet Gynecol. 2007; 196(1):65.e1-5. DOI: 10.1016/j.ajog.2006.06.094. View